Background. Postopertative adjuvant chemoradiotherapy recently became an established modality for patients with selected high-risk locally advanced head and neck cancers. The optimal treatment of unknown primary squamous cell cancer of the head and neck (SCCHN) continues to be controversial, since m
A contemporary review of indications for primary surgical care of patients with squamous cell carcinoma of the head and neck
โ Scribed by Christine G. Gourin; Jonas T. Johnson
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 131 KB
- Volume
- 119
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The success of organ preservation protocols in laryngeal cancer has led to an increase in the use of primary chemoradiation in both laryngeal and extralaryngeal sites, despite a paucity of randomized controlled clinical trial data comparing nonoperative treatment to the gold standard of surgery followed by postoperative radiation for adverse pathologic features for head and neck cancer, and an increasing recognition that the high surgical salvage rates enjoyed by laryngeal cancer patients do not translate to extralaryngeal sites. These data suggest that there is a need to apply more rigorous standards to the use of organ preservation strategies and offer an opportunity to review the role of primary surgery in head and neck cancer. Laryngoscope, 2009
๐ SIMILAR VOLUMES
Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant
## Abstract The role of the immune system in the pathogenesis and treatment of cancer is currently a popular area of research. An underlying fundamental concept of cancer immunology is the supposition that tumor cells express antigens differently than normal cells, both qualitatively and quantitati
## Abstract ## Background There is a paucity of outcomes data for patients with lymph node metastasis from cutaneous squamous cell carcinoma of head and neck (SCCHN). ## Methods Patients from a tertiary care center with cutaneous SCCHN metastatic to parotid and or cervical lymph nodes were ident